Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Non Cancer Pain × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2497 Carcinoma, Non-Small-Cell Lung 2088 Breast Neoplasms 1797 Neoplasm Metastasis 1069 Colorectal Neoplasms 1052 Prostatic Neoplasms 934 Melanoma 842 Multiple Myeloma 827 Ovarian Neoplasms 778 Recurrence 738 Leukemia, Myeloid, Acute 713 Pancreatic Neoplasms 649 Lung Neoplasms 644 Lymphoma, Non-Hodgkin 627 Lymphoma 585 Stomach Neoplasms 534 Carcinoma, Hepatocellular 490 Carcinoma, Renal Cell 474 Squamous Cell Carcinoma of Head and Neck 454 Leukemia, Lymphocytic, Chronic, B-Cell 432 Lymphoma, Follicular 400 Head and Neck Neoplasms 388 Glioblastoma 379 Advanced Solid Tumors 364 Small Cell Lung Carcinoma 350 Lymphoma, Large B-Cell, Diffuse 350 Leukemia 346 Triple Negative Breast Neoplasms 343 Uterine Cervical Neoplasms 316 Advanced Solid Tumor 309

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918098 2017-11-14

Targin for Non-cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed

Non Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡